Roche news analyzed (Farmaceut Roche, Roche)

Latest news

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

Dkoding 1 week, 3 days ago

Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare

Dkoding 1 week, 4 days ago

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Dkoding 1 month, 2 weeks ago

Changes in the Board of Directors

Dkoding 1 month, 2 weeks ago

Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant

Dkoding 1 month, 2 weeks ago

Jazz (JAZZ) Begins Zepzelca Combo Study for First-Line SCLC

Entrepreneur 1 month, 3 weeks ago

Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases

Dkoding 1 month, 3 weeks ago

Here’s Why Roche Stock May Continue To Trend Higher

Forbes 2 months, 1 week ago

Roche ranked as one of the top three most sustainable healthcare companies in the Dow Jones Sustainability Indices for the thirteenth year running

Dkoding 2 months, 1 week ago

Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease

Dkoding 2 months, 1 week ago

Roche

Latest news

Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care

Roche introduces cobas infinity edge, a new open digital ecosystem for point of care professionals, driving improved patient outcomes and operational efficiencies in healthcare

Roche to launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark to enable rapid differentiation of viral respiratory infections

Changes in the Board of Directors

Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant

Jazz (JAZZ) Begins Zepzelca Combo Study for First-Line SCLC

Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases

Here’s Why Roche Stock May Continue To Trend Higher

Roche ranked as one of the top three most sustainable healthcare companies in the Dow Jones Sustainability Indices for the thirteenth year running

Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease

Trending news

[Ad hoc announcement pursuant to Art. 53 LR] Roche announces the repurchase of the equity stake held by Novartis in Roche

IMPACT trial data shows clear benefit in using Roche’s CINtec PLUS Cytology test for women who are at higher risk of developing cervical cancer

Roche launches comprehensive genomic profiling kit to expand access to personalised cancer research

Roche’s VENTANA PD-L1 (SP263) Assay receives FDA approval as a companion diagnostic to identify certain non-small cell lung cancer patients eligible for Tecentriq® (atezolizumab)

Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raised

Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication

Coronavirus: Australia seeks Singapore travel bubble as Sydney eases curbs

US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

Roche announces PathAI collaboration for artificial intelligence-based digital pathology applications for improved patient care

Roche Chart

Who, What & Where

European Union

Wereldgezondheidsorganisatie

Pfizer

Sydney (City)

Delta (City)

Basel (City)

Roche Map